| # | Drug | Count |
|---|---|---|
| 0 | RIBAVIRIN | 55 |
| 1 | TACROLIMUS | 55 |
| 2 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 52 |
| 3 | TACROLIMUS OINTMENT 0.1% | 52 |
| 4 | MYCOPHENOLATE MOFETIL | 36 |
| 5 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 36 |
| 6 | PREDNISONE | 28 |
| 7 | SOFOSBUVIR | 27 |
| 8 | CLOZAPINE | 22 |
| 9 | METHADONE | 20 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ACETAMINOPHEN AND ASPIRIN AND CAFFEINE | 2 | 0.0124 |
| 1 | HYDROQUINONE | 2 | 0.0034 |
| 2 | BEMPEDOIC ACID | 9 | 0.0033 |
| 3 | RALTEGRAVIR | 15 | 0.0029 |
| 4 | IMIPENEM AND CILASTATIN SODIUM | 4 | 0.0019 |
| 5 | ETRAVIRINE | 7 | 0.0016 |
| 6 | PIOGLITAZONE AND METFORMIN HYDROCHLORIDE | 2 | 0.0016 |
| 7 | CLOFAZIMINE | 9 | 0.0014 |
| 8 | SOFOSBUVIR | 27 | 0.0014 |
| 9 | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE | 2 | 0.0014 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC] | 9 | 0.0027 |
| 1 | Melanin Synthesis Inhibitor [EPC] | 2 | 0.0018 |
| 2 | alpha-Hydroxy Acid [EPC] | 2 | 0.0009 |
| 3 | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] | 43 | 0.0008 |
| 4 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 1 | 0.0008 |
| 5 | Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] | 12 | 0.0007 |
| 6 | CD38-directed Cytolytic Antibody [EPC] | 4 | 0.0007 |
| 7 | beta Lactamase Inhibitor [EPC] | 3 | 0.0007 |
| 8 | CD52-directed Cytolytic Antibody [EPC] | 13 | 0.0007 |
| 9 | Nucleoside Analog Antiviral [EPC] | 56 | 0.0007 |